Study to Assess Safety and Tolerability of KarXT With Administration of Antiemetics in Healthy Volunteers
Clinical trial NCT07681076 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07681076
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-03
- Primary completion
- 2026-11-30
- Enrollment
- 225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.